Celldex Therapeutics, Inc. (CLDX)
31.76
+2.29
(+7.77%)
USD |
NASDAQ |
Mar 31, 15:42
Celldex Therapeutics Total Assets (Quarterly) : 582.98M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 16.32M |
| Atossa Therapeutics, Inc. | 47.61M |
| Abeona Therapeutics, Inc. | 221.17M |
| Cell Source, Inc. | 0.2865M |
| Kiora Pharmaceuticals, Inc. | 24.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.82M |
| Shareholders Equity (Quarterly) | 527.16M |
| Debt to Equity Ratio | 0.0044 |
| Current Ratio | 10.49 |
| Net Debt Paydown Yield | 0.01% |